Acuitas Investments, LLC Fulcrum Therapeutics, Inc. Transaction History

Acuitas Investments, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$6.7 - $12.0 $680,894 - $1.22 Million	-101,626 Reduced 75.36%	33,224 $313,000
Q4 2023 Feb 02, 2024	BUY	$3.18 - $6.86 $124 - $267	39 Added 0.03%	134,850 $910,000
Q3 2023 Oct 27, 2023	SELL	$3.25 - $6.08 $13 - $24	-4 Reduced -0.0%	134,811 $598,000
Q2 2023 Aug 07, 2023	BUY	$2.26 - $3.8 $304,681 - $512,297	134,815 New	134,815 $444,000

150

52.2M

6.91M

1.9M

Ticker FULC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,038,900
Market Cap $169M
Description
Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystro...

Get notified when there are updates to the investment portfolio of Acuitas Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Acuitas Investments, LLC with notifications on news.